October Pharma
Hesham Abdul Aziz Soliman (Director)
Gamal Hafez Tekal (Chairman of the Board)
Adnan Talaal Ghazawy (Director)
Summary
History
The company has received financial support from venture capitalist groups and angel investors through four rounds of funding to date. Athira Pharma was known as M3 Biotechnology until it underwent a name change on April 11, 2019.
Mission
Vision
Key Team
Mouhsen Ali Mohamed (Individual Shareholders Representative Director)
Ahmed Mahmoud Farag (Director)
Saied Khalfan Mohamed (Representative Director)
Gamal Salah Eldin Mahmoud Awad (Director)
Amr ben Abdul Aziz Elgalal (Director)
Fatouh Mohamed Salama (Director)
Recognition and Awards
References
Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.
Hesham Abdul Aziz Soliman (Director)
Gamal Hafez Tekal (Chairman of the Board)
Adnan Talaal Ghazawy (Director)